Association Between Plasma Asprosin Levels and Gestational Diabetes Mellitus

Figures & data

Table 1 Laboratory Parameters of the Groups

	Total (n = 93) Median (Min–Max)	Group I (n = 30) Median (Min–Max)	Group II (n = 33) Median (Min–Max)	Group III (n = 30) Median (Min–Max)
HB (g/dL)	12 (9.7–14.7)	13.2 (11.1–14.7)	11.8 (9.7–13.3)	11.8 (8.9–13.3)
FBG (mg/dL)	89 (62–134)	90.5 (71–103)	84 (62–101)	91.5 (63–134)
HbA1c (%)^a	5.2 (4.3–8.2)	5.2 (4.4–5.6)	5 (4.6–6.2)	5.5 (4.3–8.2)
HOMA-IR	2.342 (0.358–24.265)	1.359 (0.358–2.857)	2.285 (0.726–7.812)	4.749 (2.468–24.265)
Insulin (IU/mL)	11.9 (1.58–62.16)	6.3 (1.58–12.9)	10.5 (3.84–32.44)	35.8 (14.56–62.16)
C-PEPTIDE (ng/mL)	2.3 (0.81–8.64)	1.5 (0.93–2.77)	2.4 (0.81–7.62)	3.2 (1.45–8.64)
Asprosin (ng/mL)	20.462 (8.146–59.503)	13.4 (8.146–17.465)	20.5 (10.318–42.334)	42.8 (29.071–59.503)

Notes: Data are summarized as mean ± standard deviation and median (min–max) values. Kruskal–Wallis test, ^aOne-way analysis of variance.

Abbreviations: HB, hemoglobin; FBG, fasting blood glucose; HbA1c, glycated hemoglobin, HOMA-IR, C-PEPTIDE.

Table 2 Results of Pairwise Comparisons

	Group Comparisons
	Group I vs II p	Group I vs III p	Group II vs III p
HB (g/dL)	<0.001	<0.001	0.995
FBG (mg/dL)	0.073	0.186	0.007
HbA1c (%)	1000	0.019	0.001
HOMA-IR	0.005	<0.001	<0.001
Insulin (uIU/mL)	0.013	<0.001	<0.001
C-PEPTIDE (ng/mL)	0.001	<0.001	0.232
Asprosin (ng/mL)	0.001	<0.001	<0.001

Figure 1 ROC curve for asprosin levels in pregnant women.